AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.

AS1411 is a quadruplex-forming oligonucleotide aptamer that targets nucleolin. It is currently in clinical trials as a treatment for various cancers. We have proposed that AS1411 inhibits cancer cell proliferation by affecting the activities of certain nucleolin-containing complexes. Here, we report that protein arginine methyltransferase 5 (PRMT5), an enzyme that catalyzes the formation of symmetrical dimethylarginine (sDMA), is a nucleolin-associated protein whose localization and activity are altered by AS1411. Levels of PRMT5 were found to be decreased in the nucleus of AS1411-treated DU145 human prostate cancer cells, but increased in the cytoplasm. These changes were dependent on nucleolin and were not observed in cells pretreated with nucleolin-specific small interfering RNA. Treatment with AS1411 altered levels of PRMT5 activity (assessed by sDMA levels) in accord with changes in its localization. In addition, our data indicate that nucleolin itself is a substrate for PRMT5 and that distribution of sDMA-modified nucleolin is altered by AS1411. Because histone arginine methylation by PRMT5 causes transcriptional repression, we also examined expression of selected PRMT5 target genes in AS1411-treated cells. For some genes, including cyclin E2 and tumor suppressor ST7, a significant up-regulation was noted, which corresponded with decreased PRMT5 association with the gene promoter. We conclude that nucleolin is a novel binding partner and substrate for PRMT5, and that AS1411 causes relocalization of the nucleolin-PRMT5 complex from the nucleus to the cytoplasm. Consequently, the nuclear activity of PRMT5 is decreased, leading to derepression of some PRMT5 target genes, which may contribute to the biological effects of AS1411.

[1]  Vincent Nègre,et al.  Negative regulation of transcription by the type II arginine methyltransferase PRMT5 , 2002, EMBO reports.

[2]  M. Hirai,et al.  Nuclear Targeting by the Growth Factor Midkine , 2002, Molecular and Cellular Biology.

[3]  S. Pongor,et al.  Nerve growth factor‐mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1 , 2002, Journal of neuroscience research.

[4]  Hubing Shi,et al.  The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. , 2006, Blood.

[5]  Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation , 2006, Oncogene.

[6]  I G Campbell,et al.  ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix , 2006, Oncogene.

[7]  D. Angelov,et al.  Nucleolin is a histone chaperone with FACT‐like activity and assists remodeling of nucleosomes , 2006, The EMBO journal.

[8]  P. Bouvet,et al.  Nucleolin: a multiFACeTed protein. , 2007, Trends in cell biology.

[9]  G. Bonora,et al.  Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding , 2004, Cancer Gene Therapy.

[10]  H. Pollard,et al.  Molecular dissection of nucleolin's role in growth and cell proliferation: new insights , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  M. Azim Surani,et al.  Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells , 2006, Nature Cell Biology.

[12]  P. Bates,et al.  Extended phase I study of AS1411 in renal and non-small cell lung cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Bates,et al.  Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. , 2002, Biochemistry.

[14]  S. Dimitrov,et al.  Functions of the histone chaperone nucleolin in diseases. , 2007, Sub-cellular biochemistry.

[15]  M. Takagi,et al.  Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.

[16]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[17]  Oreste Acuto,et al.  Protein arginine methylation in lymphocyte signaling. , 2006, Current opinion in immunology.

[18]  P. Bates,et al.  Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding* , 1999, The Journal of Biological Chemistry.

[19]  P. Bates,et al.  Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin* , 2003, The Journal of Biological Chemistry.

[20]  Paula J. Bates,et al.  AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin , 2006, Molecular Cancer Therapeutics.

[21]  Mathieu Carpentier,et al.  Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. , 2004, European journal of biochemistry.

[22]  D. Hernandez-Verdun,et al.  Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. , 1997, Cytometry.

[23]  A. Munnich,et al.  A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy. , 2002, Human molecular genetics.

[24]  Sharmistha Pal,et al.  Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes , 2004, Molecular and Cellular Biology.

[25]  P. DiMario,et al.  Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain , 2003, Chromosoma.

[26]  C. Fenselau,et al.  Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance. , 2005, Journal of proteome research.

[27]  S. Nisole,et al.  The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. , 2000, Experimental cell research.

[28]  P. Bates,et al.  Biophysical and biological properties of quadruplex oligodeoxyribonucleotides. , 2003, Nucleic acids research.

[29]  M. Dietel,et al.  Nucleolin as Activator of Human Papillomavirus Type 18 Oncogene Transcription in Cervical Cancer , 2002, The Journal of experimental medicine.

[30]  C. D. Krause,et al.  Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. , 2007, Pharmacology & therapeutics.

[31]  N. Maizels,et al.  High Affinity Interactions of Nucleolin with G-G-paired rDNA* , 1999, The Journal of Biological Chemistry.

[32]  François-Michel Boisvert,et al.  A Proteomic Analysis of Arginine-methylated Protein Complexes* , 2003, Molecular & Cellular Proteomics.

[33]  Nam-Soon Kim,et al.  Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  Pamela A. Silver,et al.  State of the Arg Protein Methylation at Arginine Comes of Age , 2001, Cell.

[35]  W. Mcgregor,et al.  Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides* , 2001, The Journal of Biological Chemistry.

[36]  Z. Hall.  Cancer , 1906, The Hospital.

[37]  D. Treré,et al.  The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[38]  Tapas K Sengupta,et al.  Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. , 2007, Blood.

[39]  F. Ducongé,et al.  Aptamers against extracellular targets for in vivo applications. , 2005, Biochimie.

[40]  P. Wernet,et al.  Nucleolin Regulates Gene Expression in CD34-positive Hematopoietic Cells* , 2007, Journal of Biological Chemistry.

[41]  N. Takahashi,et al.  Isolation and proteomic characterization of the major proteins of the nucleolin‐binding ribonucleoprotein complexes , 2001, Proteomics.

[42]  Bruce Tidor,et al.  Proteomic Identification of 14-3-3ζ as a Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Substrate: Role in Dimer Formation and Ligand Binding , 2003, Molecular and Cellular Biology.

[43]  A. Boutanaev,et al.  Transcriptional regulation by Modulo integrates meiosis and spermatid differentiation in male germ line , 2006, Proceedings of the National Academy of Sciences.

[44]  Erkki Ruoslahti,et al.  Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels , 2003, The Journal of cell biology.

[45]  F. Vogel,et al.  Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin , 1999, Current Biology.

[46]  J. Thrasher,et al.  Lithium suppresses cell proliferation by interrupting E2F–DNA interaction and subsequently reducing S–phase gene expression in prostate cancer , 2007, The Prostate.

[47]  Graydon B. Gonsalvez,et al.  The Sm-Protein Methyltransferase, Dart5, Is Essential for Germ-Cell Specification and Maintenance , 2006, Current Biology.

[48]  Sharmistha Pal,et al.  Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma , 2007, The EMBO journal.

[49]  H. Gehring,et al.  Protein arginine methylation: Cellular functions and methods of analysis. , 2006, Biochimica et biophysica acta.

[50]  S. Pongor,et al.  Nω-arginine dimethylation modulates the interaction between a Gly/Arg-rich peptide from human nucleolin and nucleic acids , 2001 .